EVA: a Foundation Model Advancing Translational Drug Development in Immuno-Inflammation
Aziz Fouché, Apolline Bruley, Matthew Corney, Pierre Marschall, Vincent Bouget, Julien Duquesne
EVA predicts drug responses in immunology and inflammation diseases using a pre-trained foundation model, improving early trial outcome prediction and guiding drug development strategies.
bioRxiv · May 2, 2025 · PreprintBioinformatics